Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sotorasib in Previously Treated KRAS p.G12C Mutated NSCLC
NCT05631249Phase 2Recruiting
- Sponsor
- Gustave Roussy
- Start
- Dec 2022
- Primary completion
- Dec 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sotorasib in non-small cell lung cancer (NSCLC), sponsored by Gustave Roussy. Started Dec 2022; status: recruiting.
02
Drugs
sotorasib
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT05631249.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05631249.